Effect of type 2 diabetes mellitus on brain metabolites by using proton magnetic resonance spectroscopy - A systematic review

International Journal of Pharma and Bio Sciences

Volumn 5, Issue 4, 2014, Pages B1118-B1123

  Santhakumari, Rajani ^a   Reddy, Indla Yogananda ^a  

^a Mediciti Institute of Medical Sciences   (India)

^b SAVEETHA MEDICAL COLLEGE AND HOSPITAL   (India)

Author keywords

Brain metabolites; Cognition; Proton Magnetic Resonance Spectroscopy of brain; Type 2 diabetes mellitus

Indexed keywords

4 AMINOBUTYRIC ACID; CHOLINE; CREATINE; GLUTAMIC ACID; GLUTAMINE; INOSITOL; N ACETYLASPARTIC ACID;

AMINO ACID BRAIN LEVEL; BASAL GANGLION; BRAIN BLOOD FLOW; BRAIN METABOLISM; COGNITIVE DEFECT; DISEASE ASSOCIATION; FRONTAL LOBE; GLUCOSE BRAIN LEVEL; HIPPOCAMPUS; HUMAN; METABOLITE; NON INSULIN DEPENDENT DIABETES MELLITUS; OCCIPITAL LOBE; PARIETAL LOBE; PROTON NUCLEAR MAGNETIC RESONANCE; REVIEW; RISK FACTOR; SYSTEMATIC REVIEW; THALAMUS;

EID: 84907974846     PISSN: None     EISSN: 09756299     Source Type: Journal    
DOI: None     Document Type: Review

References (33)

1. Guariguata L, Whiting DR, Beagley J, Linnenkamp U, Hambleton I, Cho NH, et al. Global estimates of diabetes prevalence in adults for 2013 and projections for 2035. Diabetes Research and Clinical Practice, 103 (2): 137-149, (2014).
2. McCall AL, The impact of diabetes on the CNS. Diabetes, 41: 557-570, (1992).
3. Vinik AI, Holland MT, Le Beau JM, Liuzzi FJ, Stansberry KB, Colen LB. Diabetic neuropathies. Diabetes Care, 15: 1926-19753, (1992).
4. Biessels GJ, Kappelle AC, Bravenboer B, Erkelens DW, Gispen WH. Cerebral function in diabetes mellitus. Diabetologia, 37: 643-6504, (1994).
5. Strachan MW, Price JF, Frier BM. Diabetes, cognitive impairment, and dementia. BMJ, 336:6, (2009).
6. Mukesh G. Gohel, Evaluation of glycemic control in patients with type 2 diabetes mellitus with and without microvascular complications International Journal of Pharma and Bio Sciences, 4 (4): 794-802, (2013).
7. Rajani Santhakumari, Yogananda Reddy Indla, Satish Kumar, Archana.R. Study of cognition in type 2 diabetes with yoga asana and pranayama RJPBCS 3(2) 1637-1641, (2013).
8. Christopher T. Kodl and Elizabeth R. Seaquist, Cognitive Dysfunction and Diabetes Mellitus, Endocrine Reviews, 29(4):494-511, (2008).
9. Débora Bertholdo, MD, Arvemas Watcharakorn, MD, Mauricio Castillo, MD, Brain Proton Magnetic Resonance Spectroscopy Introduction and Overview. NeuroimagClin N Am, 23: 359-380, (2013).
10. Williams SR, In vivo proton spectroscopy: experimental aspects and potential. In: Rudin M (ed) NMR basic principles and progress, Springer, Berlin, 55-71, (1992).
11. Soares, D. P. and M. Law. Magnetic resonance spectroscopy of the brain: review of metabolites and clinical applications. Clin Radiol, 64 (1): 12-21, (2009).
12. Ajilore O, Haroon E, Kumaran S, Darwin C, Binesh N, Mintz J, Miller J, Thomas MA, Kumar A, Measurement of brain metabolites in patients with type 2 diabetes and major depression using proton magnetic resonance spectroscopy. Neuropsychopharmacology, 32: 1224-1231, (2007).
13. Geissler A, Frund R, Scholmerich J, Feuerbach S, Zietz B, Alterations of cerebral metabolism in patients with diabetes mellitus studied by proton magnetic resonance spectroscopy. Exp Clin Endocrinol Diabetes, 111: 421-427, (2003).
14. Kario K, Ishikawa J, Hoshide S, Matsui Y, Morinari M, Eguchi K, Ishikawa S, Shimada K, Diabetic brain damage in hypertension: role of renin-angiotensin system. Hypertension, 45: 887-893, (2005).
15. Kreis R, Ross BD, Cerebral metabolic disturbances in patients with subacute and chronic diabetes mellitus: detection with proton MR spectroscopy. Radiology, 184:123-130, (1992).
16. Modi S, Bhattacharya M, Sekhri T, Rana P, Tripathi RP, Khushu S, Assessment of the metabolic profile in type 2 diabetes mellitus and hypothyroidism through proton MR spectroscopy. Magn Reson Imaging, 26:420-425, (2008).
17. Sahin I, Alkan A, Keskin L, Cikim A, Karakas HM, Firat AK, Sigirci A, Evaluation of in vivo cerebral metabolism on proton magnetic resonance spectroscopy in patients with impaired glucose tolerance and type 2 diabetes mellitus. J Diabetes its Complications, 22:254-260, (2008).
18. Van Harten B, de Leeuw FE, Weinstein HC, Scheltens P, Biessels GJ. Brain imaging in patients with diabetes: a systematic review. Diabetes Care, 29:2539-2548, (2006).
19. Manschot SM, Brands AM, van der Grond J, Kessels RP, Algra A, Kappelle LJ, Biessels GJ, on behalf of the Utrecht Diabetic Encephalopathy Study Group: Brain magnetic resonance imaging correlates of impaired cognition in patients with type 2 diabetes. Diabetes, 55: 1106-1113, (2006).
20. Van Harten B, Oosterman J, Muslimovic D, van Loon BJ, Scheltens P, Weinstein C: Cognitive impairment and MRI correlates in the elderly patients with type 2 diabetes mellitus. Age Ageing, 36: 164-170, (2007).
21. Ebrahim Haroon, Kecia Watari, Albert Thomas, Olusola Ajilore, Jim Mintz, Virginia Elderkin-Thompson, Christine Darwin, Senthil Kumaran, Anand Kumar, Prefrontal myoinositol concentration and visuospatial functioning among diabetic depressed patients. Psychiatry Research: Neuroimaging, 17: 10-19, (2009).
22. Elizabeth R. Seaquist, T, Ivan Tkac, Greg Damberg, William Thomas, Rolf Gruetter, Brain glucose concentrations in poorly controlled diabetes mellitus as measured by high-field magnetic resonance spectroscopy, Metabolism Clinical and Experimental, 54: 1008-1013, (2005).
23. A.Geissler, R.Frund, J.Scholmerich, S.Feverbach, BZietz, Alterations of cerebral metabolism in patients with diabetes mellitus studied by Proton Magnetic Resonance Spectroscopy. Exp Clin Endocrinol Diabetes, 111:421-427, (2003).
24. Sanjeev Sinha, Meera Ekka, Uma Sharma, Raghunandan P, R M Pandey and N R Jagannathan, Assessment of changes in brain metabolites in Indian patients with type 2 diabetes mellitus using proton magnetic resonance spectroscopy. BMC Research Notes, 7: 41, (2014).
25. Y. Lin, J. Zhou, L. Sha, Y. Li, X. Qu, L. Liu, H. Chen, Z. An, Y. Wang, and C. Sun, Metabolite Differences in the Lenticular Nucleus in type 2 Diabetes Mellitus shown by Proton MR Spectroscopy. Am J Neuro Radiology, 34:1692-96, (2013).
26. Petrou M, Pop-Busui R, Foerster BR, Edden RA, Callaghan BC, Harte SE, Harris RE, Clauw DJ, Feldman EL, Altered Excitation-inhibition balance in the brain of patients with Diabetic Neuropathy. Acad Radiol, 19 (5): 607-612, (2009).
27. Xia Ge, Xiao-Yun Xu, Chun-Hua Feng, Yue Wang, Yuan-Ling Li and Bo Feng, Relationships among serum C-reactive protein, receptor for advanced glycation products, metabolic dysfunction and cognitive impairments. BMC Neurology, 13: 110, (2013).
28. McEwen BS. The neurobiology of stress: from serendipity to clinical relevance. Brain Res, 886: 172-189, (2000).
29. Kreis R, Ross BD. Cerebral metabolic disturbances in patientswith sub-acute and chronic diabetes mellitus: detection with proton MR spectroscopy. Radiology, 184: 123-130, (1992).
30. Kantarci K, Petersen RC, Przybelski SA, et al., Hippocampal volumes, proton magnetic resonance spectroscopy metabolites, and cerebrovascular disease in mild cognitive impairment subtypes. Arch Neurol, 65(12): 1621-8, (2008).
31. Po Lai Yau, David Javier, Wai Tsui, Victoria Sweat, Hannah Bruehl, Joan C. Borod, and Antonio Convit, Emotional and neutral declarative memory impairments and associated white matter microstructural abnormalities in adults with type 2 diabetes. J Psychiatry Res, 174(3): 223-230, (2009).
32. Audrey Tiehuis & Femke van der Meer & Willem Mali & Marc Pleizier & Geert Jan Biessels & Jaap Kappelle & Peter Luijten, MR Spectroscopy of cerebral white matter in type 2 diabetes: no association with clinical variables and cognitive performance. Neurobiology, 52: 155-161, (2010).
33. Min Zhang, Xinhai Sun, Zhengjun Zhang, Qiang Meng, Yuzhong Wang, Jing Chen, Xueqin Ma, Houfa Geng, and Lin Sun, Brain metabolite changes in patients with type 2 diabetes and cerebral infarction using proton magnetic resonance spectroscopy. International Journal of Neuroscience, 124(1):37-41, (2014).